Ardian completed the acquisition of a majority stake in Masco Group from RSBG.

Ardian, a private investment house, completed the acquisition of a majority stake in Masco Group, a provider of engineered solutions for the pharmaceutical and biotech industries, from RSBG, the holding subsidiary of RAG-Stiftung. Financial terms were not disclosed. "We are extremely happy to partner up with Luca Borella and his family to lead the next phase of growth of Masco. Together with RSBG, Luca and the management have created a global player in advanced engineering solutions for the life sciences industry. We are convinced that Masco is ideally poised to benefit from long-term tailwinds in the biotech industry, due to its deep engineering and process knowledge. We look forward to accelerating the Company’s international development organically and through an ambitious M&A strategy. This transaction is testament to Ardian’s expertise in investing in the most attractive niches within healthcare and partnering with leading entrepreneurial families," Marco Bellino, Ardian Deputy Head of Buyout Italy & Managing Director.